Up to 21 million people around the world have been diagnosed with some type of schizophrenic disorder. It is one of the most complex diseases.
CBD is the second most common phytocannabinoid in the Cannabis plant. Unlike his brother, THC, which can aggravate psychosis – and is psychoactive – has important antipsychotic properties among others.
Like other prescribed antipsychotics, it affects “positive” (active) symptoms such as hallucinations or paranoia, focused on acting on dopamine receptors. The novelty is that it helps to alleviate the patient's “negative” (passive) symptoms such as depression, insomnia, apathy and anxiety by regulating the serotonergic system.
Patients who used CBD had less cerebral cognitive deterioration and greater gray matter density. In addition, it has no side effects even using it in high concentrations.